• Customer portal
logo logo
  • Start
  • Products
    • Our products
    • Ultrasound
    • Radiography
    • MRI
    • Mammography
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • News
    • Events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About ContextVision
    • Management
    • Board of directors
    • Career
    • ContextVision quality policy
  • Contact
    • Sales Digital Pathology
    • Sales OEM Medical Imaging
    • OEM Medical Imaging
    • Investor relations & Media
    • Digital Pathology
    • Headquarters
  • HEJ!
    • Research & Development
    • Artificial intelligence
    • The GOP technology
logo logo
  • Start
  • Products
    • Our products
    • Ultrasound
    • Radiography
    • Magnetic Resonance Imaging
    • Mammography
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
  • News
    • Latest news
    • Latest events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About
    • Management
    • Board of Directors
    • Career
    • ContextVision quality policy
  • Contact
In The Media2009-12-10

Dropping the Dose: A Priority at RSNA

DOTmed News 

Dropping the Dose: A Priority at RSNA, Dec 8

Article including an interview of Don Berry, Ph.D., X-ray product manager of ContextVision AB

Previous RSNA Video Profile: ContextVision – Video presentation by Don Barry, Ph.D., X-ray product manager of ContextVision AB
Next Johns Hopkins University Study Proves Low-dose Capability of ContextVision Interventional Image Enhancement Tool
© ContextVision AB (publ)